HealthDay News — For patients with unresectable metastatic uveal melanoma (mUM), the drug/device combination melphalan/hepatic delivery system (HDS) is efficacious and has a favorable risk-benefit ...

FDA to establish national standard and timeline for food industry to transition from petrochemical-based dyes to natural alternatives.

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

Meanwhile, a new registry is being created to track those with autism, and that information will be part of the database.

The FDA issues alert regarding compounded topical finasteride; plant-based alkaloid shows improvements for smoking cessation; potential new treatment option for GERD; and the CDC’s Advisory ...

“Tegoprazan offers an exciting new treatment option for individuals suffering from GERD, helping to address the substantial unmet need of patients not well-controlled by conventional PPI therapy,” ...

This follows a major move by the US Food and Drug Administration (FDA) in January, under former President Joe Biden, to ban red dye No. 3 in food, drinks and some drugs. That action came more than 30 ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to BA-102 for the treatment of Phelan-McDermid syndrome, a rare neurodevelopmental disorder linked to autism.

All the scientists were fired from the only STI lab in the US that tested how well antibiotics were working against drug-resistant gonorrhea strains.

"Although vaccines will remain the primary control measure for influenza epidemics and pandemics, antiviral drugs play a complementary role." HealthDay News — A single-dose baloxavir treatment ...

Dr David Sugerman, a senior scientist at the CDC, said that the agency is "scraping to find the resources" to support states affected by the outbreaks.

After 3 initial monthly injections, current dosing intervals range from every 8 to 16 weeks in patients with wAMD and DME and every 8 to 12 weeks in patients with DR.